Pharmacological profile of YM087, a novel nonpeptide dual vasopressin V 1A and V 2 receptor antagonist, in dogs

By Yatsu T.   Tomura Y.   Tahara A.   Wada K.-i.   Tsukada J.   Uchida W.   Tanaka A.   Takenaka T.  

European Journal of Pharmacology, Vol. 321, Iss. 2, 1997-02 ,pp. : 225-230

Elsevier

Access to resources Recommend Favorite

In vivo and in vitro characterisation of a nonpeptide vasopressin V 1A and V 2 receptor antagonist (YM087) in the rat

By Risvanis J.   Naitoh M.   Johnston C.I.   Burrell L.M.  

European Journal of Pharmacology, Vol. 381, Iss. 1, 1999-09 ,pp. : 23-30

Elsevier

Access to resources Recommend Favorite

Cardiovascular and renal effects of conivaptan hydrochloride (YM087), a vasopressin V 1A and V 2 receptor antagonist, in dogs with pacing-induced congestive heart failure

By Yatsu T.   Tomura Y.   Tahara A.   Wada K.-i.   Kusayama T.   Tsukada J.   Tokioka T.   Uchida W.   Inagaki O.   Iizumi Y.   Tanaka A.   Honda K.  

European Journal of Pharmacology, Vol. 376, Iss. 3, 1999-07 ,pp. : 239-246

Elsevier

Access to resources Recommend Favorite

Pharmacological profile of YM358, a novel nonpeptide angiotensin AT1 receptor antagonist

By Shibasaki M.   Fujimori A.   Takanashi M.   Kusayama T.   Tokioka T.   Satoh Y.   Okazaki T.   Uchida W.   Inagaki O.   Yanagisawa I.  

European Journal of Pharmacology, Vol. 335, Iss. 2, 1997-09 ,pp. : 167-173

Elsevier

Access to resources Recommend Favorite

EFFECT OF CONIVAPTAN, A COMBINED VASOPRESSIN V_1a AND V₂ RECEPTOR ANTAGONIST, ON VASOPRESSIN-INDUCED CARDIAC AND HAEMODYNAMIC CHANGES IN ANAESTHETISED DOGS

By Yatsu T.   Kusayama T.   Tomura Y.   Arai Y.   Aoki M.   Tahara A.   Wada K-I.   Tsukada J.  

Pharmacological Research, Vol. 46, Iss. 5, 2002-11 ,pp. : 375-381

Academic Press

Access to resources Recommend Favorite